血管造影カテーテルの世界市場-2023-2030

市場概要

血管造影カテーテルの世界市場は、2022年に12億5,730万米ドルに達し、2030年には22億2,980万米ドルに達することで有利な成長を示すと予測されます。世界の血管造影カテーテル市場は、予測期間（2023年～2030年）に7.6%のCAGRを示すと予想されています。医療機器の急速な技術進歩や、ヘルスケアインフラ構築のための政府支出の増加が、世界の血管造影カテーテル市場を牽引する重要な要因となっています。

血管造影カテーテルは、インターベンショナル・カーディオロジーや放射線学の分野で非常に重要な役割を担っています。これらのカテーテルは、血管を観察し、診断や治療を行うために使用される特殊な医療機器です。

市場力学

心血管疾患の有病率の増加

冠動脈疾患、末梢動脈疾患、心臓発作などの心血管疾患の発生率が上昇しているため、診断および介入処置の必要性が高まっています。血管造影カテーテルは、血管を可視化し評価する血管造影の実施に不可欠なツールであり、これらの疾患の診断と治療を支援します。

また、技術的な進歩は、その性能と安全性を向上させたような形で血管造影市場を牽引しています。画像処理能力の向上、優れたカテーテル素材、操作性の向上などの技術革新により、処置がより正確で低侵襲になり、これらのカテーテルの採用や需要の増加につながりました。

厳しい規制要件

血管造影カテーテル市場は、様々な医療機器に関する規制を遵守し、厳しい監督下におかれています。これらの要件を満たすことは、製品開発と承認に関連する時間とコストを増加させる可能性があります。

保険会社による償還政策と保険適用は、血管造影カテーテルの導入に影響を与える可能性があります。償還率が低い場合、または血管造影カテーテルを含む特定の処置が保険適用外である場合、ヘルスケア施設やプロバイダーはこれらの機器への投資や処置の実施に消極的になる可能性があります。

COVID-19の影響分析

血管造影カテーテル市場は、手技量の減少などさまざまな要因によって、COVID-19の影響を大きく受けました。パンデミックの間、多くの病院やヘルスケア施設では、緊急でない血管造影処置を含む選択的処置が大幅に減少しました。このような処置量の減少は、血管造影カテーテルの需要に直接影響を与えました。

ヘルスケアシステムへの負担とリソースの優先順位付けの必要性から、血管造影処置は主に緊急の症例に対して行うようにシフトしました。このシフトは、血管造影カテーテルの全体的な利用率を低下させました。

パンデミックによる世界のサプライチェーンの混乱は、血管造影カテーテルを含む医療機器の生産、流通、および入手に困難をもたらしました。製造施設は一時的な閉鎖、輸送制限、原材料の不足に直面し、遅延やサプライチェーンの中断につながりました。

目次

第1章 調査手法とスコープ

• 調査手法
• 調査目的および調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

• 製品タイプ別スニペット
• アプリケーション別
• エンドユーザー別

第4章 市場力学

• 影響要因
  • 促進要因
    • 心血管疾患の有病率の増加
  • 抑制要因
    • 厳しい規制要件
  • 機会
    • R&D活動の成長
  • 影響分析

第5章 産業分析

• ポーターの5フォース分析
• サプライチェーン分析
• 価格分析
• 法規制の分析

第6章 COVID-19の分析

• COVID-19の分析
  • COVID-19の前のシナリオ
  • COVID-19実施中のシナリオ
  • COVID-19後のシナリオ
• COVID-19の中での価格・ダイナミクス
• 需給スペクトル
• パンデミック時の市場に関連する政府の取り組み
• メーカーの戦略的な取り組み
• サマリー

第7章 製品タイプ別

• スコアリングバルーンカテーテル
• コンベンショナルカテーテル
• カッティングバルーンカテーテル
• 薬剤溶出型バルーンカテーテル

第8章 アプリケーション別

• 血管内
• 冠動脈
• 脳神経
• 腫瘍
• その他

第9章 エンドユーザー別

• 病院
• 専門クリニック
• 外来手術センター
• その他

第10章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ地域

第11章 競合情勢

• 競合シナリオ
• 市況ポジショニング/シェア分析
• M&A（合併・買収）分析

第12章 企業プロファイル

• Medtronic
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展状況
• Boston Scientific Corporation
• Terumo Medical Corporation
• Cardinal Health
• Merit Medical Systems, Inc.
• Abbott
• Aachen Resonance Entwicklungsgesellschaft Mbh
• ZOLL Medical Corporation
• Contego Medical, Inc
• Asahi Intecc Co. Ltd.

第13章 付録

Market Overview

The Global Angiographic Catheters Market reached US$ 1,257.3 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 2,229.8 million by 2030. The global angiographic catheters market is expected to exhibit a CAGR of 7.6% during the forecast period (2023-2030). Rapid technical advancements in medical equipment, as well as rising government expenditures for the construction of healthcare infrastructure, are important factors driving the global angiographic catheters market.

Angiographic catheters are extremely important in the fields of interventional cardiology and radiology. These catheters are specialized medical devices that are used to see blood vessels and perform diagnostic and therapeutic treatments.

Market Dynamics

Increasing Prevalence of Cardiovascular Diseases

The rising incidence of cardiovascular conditions such as coronary artery disease, peripheral artery disease, and heart attacks has led to a growing need for diagnostic and interventional procedures. Angiographic catheters are essential tools in performing angiography to visualize and assess blood vessels, aiding in the diagnosis and treatment of these diseases.

Also, technological advancements drive the angiographic market in such a way that it has improved their performance and safety. Innovations such as improved imaging capabilities, better catheter materials, and enhanced maneuverability have made procedures more accurate and minimally invasive, leading to increased adoption and demand for these catheters.

Stringent Regulatory Requirements

The angiographic catheter market is subject to strict regulatory oversight and compliance with various medical device regulations. Meeting these requirements can increase the time and cost associated with product development and approval.

Reimbursement policies and coverage by insurance providers can impact the adoption of angiographic catheters. If reimbursement rates are low or if certain procedures involving angiographic catheters are not covered, healthcare facilities and providers may be reluctant to invest in these devices or perform the procedures.

COVID-19 Impact Analysis

The angiographic catheters market was hugely affected by COVID-19 through various factors like decreased procedure volumes. During the pandemic, many hospitals and healthcare facilities experienced a significant reduction in elective procedures, including non-emergency angiographic procedures. This decline in procedure volumes directly affected the demand for angiographic catheters.

Due to the strain on healthcare systems and the need to prioritize resources, there was a shift towards performing angiographic procedures primarily for urgent or emergency cases. This shift reduced the overall utilization of angiographic catheters.

The global supply chain disruptions caused by the pandemic resulted in challenges in the production, distribution, and availability of medical devices, including angiographic catheters. Manufacturing facilities faced temporary closures, transportation restrictions, and shortages of raw materials, leading to delays and supply chain interruptions.

Segment Analysis

The global angiographic catheters market is segmented based on product type, application and end user.

The Scoring Balloon Catheters in Product Segment will be Dominated by Market Players During the Forecast Period

The scoring balloon catheters segment is expected to hold a substantial share of around 37.2% in the angiography catheter market. Where scoring balloon catheters are used during certain interventional procedures, both scoring balloon catheters and angiography catheters may be used in sequence. For example, during an angioplasty procedure, an angiography catheter is first used to obtain diagnostic images of the affected blood vessels. Once the lesion has been identified, a scoring balloon catheter may be introduced to facilitate lesion modification and optimize vessel dilation.

Geographical Analysis

North America is the Dominating Region Accounting for 41.7% During the Forecast Period

North America is the dominating region for the angiographic catheters market due to well-developed healthcare infrastructure and a high level of healthcare spending, which further supports the market growth. Technological advancements in angiographic catheters, such as the development of new materials, improved designs, and enhanced imaging capabilities, also contribute to market expansion.

Factors that influence the market for angiographic catheters include the prevalence of cardiovascular diseases, advancements in technology, healthcare infrastructure, and reimbursement policies. North America, particularly the United States, has a significant burden of cardiovascular diseases, which drives the demand for angiographic catheters.

Competitive Landscape

The major global players include: Medtronic, Boston Scientific Corporation, Terumo Medical Corporation, Cardinal Health, Merit Medical Systems, Inc, Abbott, Aachen Resonance Entwicklungsgesellschaft Mbh, Zoll Medical Corporation, Contego Medical, Inc, and Asahi Intecc Co. LTD.

Why Purchase the Report?

• To visualize the global angiographic catheters market segmentation based on the treatment, application, end user and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of global angiographic catheters market level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global angiographic catheters market report would provide approximately 92 tables, 108 figures and 195 pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Application
• 3.3. Snippet by End User

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing prevalence of cardiovascular diseases
  • 4.1.2. Restraints
    • 4.1.2.1. Stringent Regulatory Requirements
  • 4.1.3. Opportunity
    • 4.1.3.1. Growth in R & D activities
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's 5 Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID-19
  • 6.1.2. Scenario During COVID-19
  • 6.1.3. Scenario Post COVID-19
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During Pandemic
• 6.5. Manufacturers Strategic Initiatives
• 6.6. Conclusion

7. By Product Type

• 7.1 Scoring Balloon Catheters
• 7.2 Conventional Catheters
• 7.3 Cutting Balloon Catheters
• 7.4 Drug-Eluting Balloon Catheters

8. By Application

• 8.1. Endovascular
• 8.2. Coronary
• 8.3. Neurology
• 8.4. Oncology
• 8.5. Others

9. By End User

• 9.1. Hospitals
• 9.2. Specialty Clinics
• 9.3. Ambulatory Surgical Centers
• 9.4. Others

10. By Region

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 10.1.2. Market Attractiveness Index, By Region
• 10.2. North America
  • 10.2.1. Introduction
  • 10.2.2. Key Region-Specific Dynamics
  • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
  • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.2.6.1. The U.S.
    • 10.2.6.2. Canada
    • 10.2.6.3. Mexico
• 10.3. Europe
  • 10.3.1. Introduction
  • 10.3.2. Key Region-Specific Dynamics
  • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
  • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.3.6.1. Germany
    • 10.3.6.2. The UK
    • 10.3.6.3. France
    • 10.3.6.4. Italy
    • 10.3.6.5. Spain
    • 10.3.6.6. Rest of Europe
• 10.4. South America
  • 10.4.1. Introduction
  • 10.4.2. Key Region-Specific Dynamics
  • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
  • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.4.6.1. Brazil
    • 10.4.6.2. Argentina
    • 10.4.6.3. Rest of South America
• 10.5. Asia-Pacific
  • 10.5.1. Introduction
  • 10.5.2. Key Region-Specific Dynamics
  • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
  • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 10.5.6.1. China
    • 10.5.6.2. India
    • 10.5.6.3. Japan
    • 10.5.6.4. Australia
    • 10.5.6.5. Rest of Asia-Pacific
• 10.6. Middle East and Africa
  • 10.6.1. Introduction
  • 10.6.2. Key Region-Specific Dynamics
  • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End user
  • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country

11. Competitive Landscape

• 11.1. Competitive Scenario
• 11.2. Market Positioning/Share Analysis
• 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

• 12.1. Medtronic
  • 12.1.1.1. Company Overview
  • 12.1.1.2. Product Portfolio and Description
  • 12.1.1.3. Financial Overview
  • 12.1.1.4. Key Developments
• 12.2. Boston Scientific Corporation
• 12.3. Terumo Medical Corporation
• 12.4. Cardinal Health
• 12.5. Merit Medical Systems, Inc.
• 12.6. Abbott
• 12.7. Aachen Resonance Entwicklungsgesellschaft Mbh
• 12.8. ZOLL Medical Corporation
• 12.9. Contego Medical, Inc
• 12.10. Asahi Intecc Co. Ltd.

LIST NOT EXHAUSTIVE

13. Appendix

• 13.1. About Us and Services
• 13.2. Contact Us